Halia Therapeutics Presented Data on Targeting the NLRP3 Inflammasome for the Treatment of Alzheimer's Disease
/PRNewswire/ -- Halia Therapeutics, a biotechnology company that has used a structure-based drug design strategy to discover a series of small molecule...
Source: prnewswire.com